Biotechnology (114) | Share Agreements (114)

Browse by Company

2seventy bio, Inc. (1)
Allogene Therapeutics, Inc. (2)
Amgen Inc. (3)
AmpliPhi Biosciences Corp (1)
Anchiano Therapeutics Ltd. (1)
Aptose Biosciences Inc. (1)
ARYA Sciences Acquisition Corp II (1)
Athenex, Inc. (2)
BeiGene, Ltd. (7)
Benitec Biopharma Inc. (1)
BICYCLE THERAPEUTICS Ltd (7)
Big Cypress Acquisition Corp. (1)
BioAtla, Inc. (1)
Biohaven Pharmaceutical Holding Co Ltd. (2)
BIOTIME INC (1)
bluebird bio, Inc. (1)
CANCER GENETICS, INC (1)
Centessa Pharmaceuticals Ltd (2)
Chardan Healthcare Acquisition Corp. (1)
CLEVELAND BIOLABS INC (1)
COMPASS Pathways plc (1)
Consonance-HFW Acquisition Corp. (1)
Cybrdi, Inc. (2)
CytomX Therapeutics, Inc. (1)
CYTORI THERAPEUTICS, INC. (1)
DBV Technologies S.A. (2)
Dicerna Pharmaceuticals Inc (2)
Dynamics Special Purpose Corp. (1)
Edge Therapeutics, Inc. (1)
Emerald Bioscience, Inc. (2)
EXICURE, INC. (1)
Fusion Pharmaceuticals Inc. (3)
GeoVax Labs, Inc. (1)
Health Sciences Acquisitions Corp (1)
Immix Biopharma, Inc. (1)
Immuneering Corp (1)
InMed Pharmaceuticals Inc. (2)
Innovation Pharmaceuticals Inc. (1)
Instil Bio, Inc. (1)
INTERCEPT PHARMACEUTICALS, INC. (2)
Invitae Corp (1)
Kiniksa Pharmaceuticals, Ltd. (6)
LianBio (5)
NOVAVAX INC (1)
Opko Health, Inc. (1)
PDL BIOPHARMA, INC. (1)
Petra Acquisition Inc. (1)
PharmaCyte Biotech, Inc. (1)
PLURISTEM THERAPEUTICS INC (1)
Prothena Corp plc (1)
Rallybio Corp (4)
Repare Therapeutics Inc. (2)
RITTER PHARMACEUTICALS INC (2)
Social Capital Suvretta Holdings Corp. III (1)
Spero Therapeutics, Inc. (1)
SPHERIX INC (1)
Spinning Eagle Acquisition Corp. (2)
Sunshine Biopharma, Inc (2)
Synthetic Biologics, Inc. (2)
TYME TECHNOLOGIES, INC. (1)
Vaccitech plc (1)
Vaxxinity, Inc. (1)
Xenetic Biosciences, Inc. (5)
Xenon Pharmaceuticals Inc. (2)
Zai Lab Ltd (1)
Zymeworks Inc. (1)

Recent Contracts

Amendment No. 3 to Share Purchase Agreement, dated January 30, 2023, by and among BeiGene, Ltd. and Amgen Inc (Amgen Inc., Filed With SEC on January 31, 2023)
Amendment No. 1 to the Share Purchase Agreement (Emerald Bioscience, Inc., Filed With SEC on January 27, 2023)
Form of Share Purchase Agreement (Immix Biopharma, Inc., Filed With SEC on January 18, 2023)
Share Purchase Agreement, dated December 30, 2022, by and between vivoPharm Pty, Ltd. and Sabine Brandt as trustee for the Brandt Family Trust (CANCER GENETICS, INC, Filed With SEC on January 5, 2023)
Share Transfer Agreement by and between PDS Biotechnology Corporation and Merck KGaA, Darmstadt, Germany (Edge Therapeutics, Inc., Filed With SEC on January 3, 2023)
Share Purchase Agreement, dated November 8, 2022, by and between Emerald Health Therapeutics, Inc., 14428773 Canada Inc., Verdelite Sciences, Inc., Verdelite Property Holdings,... (Emerald Bioscience, Inc., Filed With SEC on November 14, 2022)
Form of Restricted Share Unit Award Agreement (Zai Lab Ltd, Filed With SEC on November 9, 2022)
Share Purchase Agreement between Sunshine Biopharma, Inc., Malek Chamoun and Nora Pharma Inc (Sunshine Biopharma, Inc, Filed With SEC on October 20, 2022)
First Amendment to the Share Purchase Agreement, dated May 11, 2022, by and among the Registrant, Overland Pharmaceuticals (CY) Inc. and Allogene Overland Biopharm (CY) Limited (Allogene Therapeutics, Inc., Filed With SEC on August 9, 2022)
Form of Inducement Award Non-Qualified Share Option Agreement (COMPASS Pathways plc, Filed With SEC on August 4, 2022)